|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 305.96 USD | +1.41% |
|
+3.46% | +0.98% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 8.21B 7.19B 6.67B 6.13B 11.56B 792B 11.73B 79.51B 31.12B 387B 30.8B 30.14B 1,338B | P/E 2026 * |
36.8x | P/E 2027 * | 36x |
|---|---|---|---|---|---|
| Enterprise Value | 7.46B 6.53B 6.07B 5.57B 10.5B 719B 10.66B 72.25B 28.28B 352B 27.99B 27.39B 1,216B | EV / Sales 2026 * |
2.9x | EV / Sales 2027 * | 2.75x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +1.41% | ||
| 1 week | +3.46% | ||
| Current month | +4.21% | ||
| 1 month | +8.84% | ||
| 3 months | +1.72% | ||
| 6 months | +0.24% | ||
| Current year | +0.98% |
| 1 week | 285.39 |  | 307.49 |
| 1 month | 270 | | 307.49 |
| Current year | 236.73 | | 328.56 |
| 1 year | 236.73 | | 343.12 |
| 3 years | 211.43 | | 431.79 |
| 5 years | 211.43 | | 832.7 |
| 10 years | 142.06 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/11/26 | Sell | Executive/Senior Manager | -550 | 0.0025% | ||
| 4/24/26 | Fiscal year | General Counsel | 449 | 0.0020% | ||
| 4/24/26 | Fiscal year | Chief Financial Officer | 2,576 | 0.0117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.41% | +3.46% | +24.64% | -26.13% | 8.11B | |
| +0.90% | +12.66% | -20.01% | -12.00% | 174B | |
| -0.56% | +1.76% | -10.65% | -7.95% | 105B | |
| -0.82% | +1.35% | +2.60% | +56.07% | 58.97B | |
| +0.38% | -0.99% | +39.57% | +58.03% | 52.24B | |
| -0.44% | -1.11% | -15.51% | -42.17% | 42.39B | |
| -4.89% | -5.73% | - | - | 33.05B | |
| -4.44% | -1.79% | -16.08% | -45.31% | 28.84B | |
| -0.23% | -0.16% | +63.73% | -5.01% | 25.38B | |
| -0.56% | -0.42% | -5.87% | -9.27% | 20.64B | |
| Average | -0.75% | +2.28% | +6.94% | -3.75% | 54.86B | |
| Weighted average by Cap. | -0.08% | +4.90% | -3.49% | -0.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.25B 2.09B 1.92B 3.62B 248B 3.67B 24.88B 9.74B 121B 9.64B 9.43B 419B | 2.63B 2.31B 2.14B 1.97B 3.71B 254B 3.77B 25.53B 9.99B 124B 9.89B 9.68B 430B |
| Net income | 225M 197M 183M 168M 317M 21.7B 321M 2.18B 853M 10.62B 844M 826M 36.67B | 230M 201M 187M 172M 324M 22.17B 328M 2.23B 871M 10.85B 862M 844M 37.47B |
| Net Debt | -749M -656M -609M -560M -1.05B -72.28B -1.07B -7.26B -2.84B -35.37B -2.81B -2.75B -122B | -965M -846M -785M -722M -1.36B -93.16B -1.38B -9.36B -3.66B -45.58B -3.62B -3.55B -157B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | US$305.96 | +1.41% | 275,066 |
| 26-07-21 | US$301.70 | -0.07% | 302,880 |
| 26-07-20 | US$301.90 | -0.81% | 454,218 |
| 26-07-17 | US$304.36 | +1.12% | 287,199 |
| 26-07-16 | US$300.98 | +1.78% | 237,474 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
